Evidence map›Paper›PMID 41617223›Full record

ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2026

Patient-reported outcomes as predictors of disability evolution in Multiple Sclerosis: An interpretable machine learning approach.

Federica Di Antonio, Giampaolo Brichetto, Andrea Tacchino, Ludovico Pedullà, Jessica Podda, Erica Grange, Alice Bollini, Margherita Monti Bragadin, Valeria Prada, Matteo Bauckneht and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Federica Di AntonioNeuroBRITE Research Area, Italian Multiple Sclerosis Foundation (FISM), Genoa, Italy; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.ORCID 0009-0007-1552-0737
Giampaolo BrichettoNeuroBRITE Research Area, Italian Multiple Sclerosis Foundation (FISM), Genoa, Italy; AISM Rehabilitation Service, Italian Multiple Sclerosis Society, Genoa, Italy.ORCID 0000-0003-2026-3572
Andrea TacchinoNeuroBRITE Research Area, Italian Multiple Sclerosis Foundation (FISM), Genoa, Italy.ORCID 0000-0002-2263-7315
Ludovico PedullàNeuroBRITE Research Area, Italian Multiple Sclerosis Foundation (FISM), Genoa, Italy.ORCID 0000-0002-2547-382X
Jessica PoddaNeuroBRITE Research Area, Italian Multiple Sclerosis Foundation (FISM), Genoa, Italy.ORCID 0000-0002-9327-9148
Erica GrangeNeuroBRITE Research Area, Italian Multiple Sclerosis Foundation (FISM), Genoa, Italy; Department of Informatics, Bioengineering, Robotics and Systems Engineering (DIBRIS), University of Genova, Genova, Italy.ORCID 0000-0001-5114-9276
Alice BolliniNeuroBRITE Research Area, Italian Multiple Sclerosis Foundation (FISM), Genoa, Italy.ORCID 0000-0003-4303-4297
Margherita Monti BragadinNeuroBRITE Research Area, Italian Multiple Sclerosis Foundation (FISM), Genoa, Italy; AISM Rehabilitation Service, Italian Multiple Sclerosis Society, Genoa, Italy.ORCID 0000-0001-6368-1833
Valeria PradaNeuroBRITE Research Area, Italian Multiple Sclerosis Foundation (FISM), Genoa, Italy.ORCID 0000-0001-5756-0576
Matteo BaucknehtDepartment of Health Sciences (DISSAL), University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.ORCID 0000-0002-1937-9116
Silvia MorbelliDepartment of Medical Sciences, University of Turin, Turin, Italy.ORCID 0000-0002-7833-6095
Andrea ChincariniNational Institute for Nuclear Physics (INFN), Genoa Section, Genoa, Italy.ORCID 0000-0003-4094-9942

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDisability accrual in multiple sclerosis (MS) is highly variable and challenging to predict, complicating personalised care. Integrating machine learning (ML) with patient-reported outcomes (PROs) and clinician-assessed outcomes (CAOs) may support tailored interventions.

objectivesTo develop and validate an interpretable ML model for predicting disability accrual trajectories in MS.

methodsA multicentre data set of 1,176 MS patients with up to 8 years of follow-up was used. A random forest model was trained to predict disability accrual at 2, 3, 4, and 5 years, using baseline clinical variables, PROs and initial risk class as predictors. Model performance was assessed using accuracy, area under the curve, and survival analysis.

results437 patients composed final cohort. The model predicted disability changes with an accuracy of 0.82 (95% CI: 0.77-0.86) at 2 years and 0.73 (95% CI: 0.66-0.80) at 5 years. Initial risk class and baseline Expanded Disability Status Scale (EDSS) were the most influential predictors. Survival analysis confirmed model's ability to effectively capture the time-dependent patterns of disability accrual events at the population level (log rank

conclusionsThe model offers robust and interpretable predictions that may support clinical decision-making using routine clinical data.

Indexed as

Disease ProgressionMachine LearningMultiple SclerosisPatient Reported Outcome MeasuresAdultDisability EvaluationFemaleHumansMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsRandom Forestdisability predictionexplainabilitymachine learningMultiple sclerosispatient-reported outcomes

Identifiers

PMID41617223
PMCPMC13168606

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.